2020-2025 Global Biopharmaceuticals Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

SKU ID : Maia- 17186062

Publishing Date : 14-Jan-2021

No. of pages : 118

PRICE
3360
6720

  • A biopharmaceutical, also known as a biologic medical product, biological,or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They are isolated from living sources—human, animal, plant, fungal, or microbial.
    This report elaborates the market size, market characteristics, and market growth of the Biopharmaceuticals industry, and breaks down according to the type, application, and consumption area of Biopharmaceuticals. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

    In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Biopharmaceuticals in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
    In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

    Key players in the global Biopharmaceuticals market covered in Chapter 13:
    Novartis
    Johnson & Johnson
    Amgen
    Sanofi-Aventis
    Eli Lilly
    Roche
    AbbVie
    Novo Nordisk
    Pfizer
    Merck

    In Chapter 6, on the basis of types, the Biopharmaceuticals market from 2015 to 2025 is primarily split into:
    Monoclonal Antibodies
    Interferon
    Colony-Stimulating Factor
    Erythropoietin
    Insulin
    Vaccines
    Growth Hormones
    Others

    In Chapter 7, on the basis of applications, the Biopharmaceuticals market from 2015 to 2025 covers:
    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Others

    Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
    United States
    Europe
    China
    Japan
    India

    Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
    North America (Covered in Chapter 8)
    United States
    Canada
    Mexico
    Europe (Covered in Chapter 9)
    Germany
    UK
    France
    Italy
    Spain
    Others
    Asia-Pacific (Covered in Chapter 10)
    China
    Japan
    India
    South Korea
    Southeast Asia
    Others
    Middle East and Africa (Covered in Chapter 11)
    Saudi Arabia
    UAE
    South Africa
    Others
    South America (Covered in Chapter 12)
    Brazil
    Others

    Years considered for this report:


    Historical Years:

    2015-2019

    Base Year:

    2019

    Estimated Year:

    2020

    Forecast Period:

    2020-2025

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports